SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020371
Filing Date
2021-04-23
Accepted
2021-04-23 16:45:23
Documents
9
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A adpt-def14a_20210611.htm DEF 14A 1371484
2 GRAPHIC gug4wb5muyrt000005.jpg GRAPHIC 319411
3 GRAPHIC gug4wb5muyrt000001.jpg GRAPHIC 74467
4 GRAPHIC gug4wb5muyrt000007.jpg GRAPHIC 925936
5 GRAPHIC gug4wb5muyrt000003.jpg GRAPHIC 74467
6 GRAPHIC gug4wb5muyrt000006.jpg GRAPHIC 10527
7 GRAPHIC gug4wb5muyrt000002.jpg GRAPHIC 4439
8 GRAPHIC gug4wb5muyrt000008.jpg GRAPHIC 77426
9 GRAPHIC gug4wb5muyrt000004.jpg GRAPHIC 10527
  Complete submission text file 0001564590-21-020371.txt   3435460
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38957 | Film No.: 21850438
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences